Skip to content

Impact of an Enhanced Patient Reported Outcome Measurement (PROM) Strategy on PROM Completion Rates

Impact of an Enhanced Patient Reported Outcome Measurement (PROM) Strategy on PROM Completion Rates, Decision Support, and Patient Experience: A Hybrid Effectiveness-Implementation Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06078137
Enrollment
200
Registered
2023-10-11
Start date
2023-09-01
Completion date
2025-12-01
Last updated
2026-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PROM

Brief summary

in clinical practice has been curbed by issues related to the variability in use of these tools for decision-making, and universally poor completion rates over time. Patients may not see the relevance of responding to questions about their health, and the results may not be reviewed by the clinician or presented and visualized with the patient. The questions may seem impersonal (e.g. too general and not directly assessing their individual goals, motivations, aspirations), irrelevant (e.g., asking about symptoms of depression when a person is seeking musculoskeletal specialty care) and insensitive (e.g., asking about sensitive subjects at the outset thereby disengaging the individual), and redundant or awkward (e.g., presenting questions that seem very similar or administered in strange orders). Finally, PROMs may also confer some burden (e.g., long PROM questionnaires often used for research may be unnecessarily burdensome for patient care), and provide logistical challenges (e.g., difficulties in administering the tools at the right time points), adding to a poor patient experience.

Detailed description

The investigator sought to assess the impact of an enhanced and more personalized PROM strategy to overcome these barriers by providing i) a primer ahead of PROMs administration, ii) simple 3-part survey capturing capability, comfort, and calm, iii) a short distress and misconception survey, iv) goal setting question, v) summary sheet of PRO scores, and vi) a commitment intervention. Patients will subsequently be requested to complete the CollaboRATE survey, JSPPE survey, and questions about their experience in relation to the new format of surveys (only if they were in the intervention group) before receiving a text message reminder around 6-weeks followed by a set of deprioritization questions and the 3-part capability, comfort, and calm survey.

Interventions

OTHERUsual PROMs and new PROMs strategy

Patients randomized to intervention receive both usual PROMs and new PROMs strategy

Sponsors

University of Texas at Austin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

All new patients English and Spanish speakers

Exclusion criteria

Cognitive deficiency precluding PROM completion Language other than English or Spanish

Design outcomes

Primary

MeasureTime frameDescription
Completion of 3-survey patient-reported outcome measure at 6-week follow-up via Textthrough study completion, an average of 6 weeksWe will assess the completion of 3-survey patient-reported outcome measure at 6-week follow-up via Text.
Completion of answered textthrough study completion, an average of 6 weeksWe will assess the completion response rate.
Completion of deprioritization options 1 or 2 at 6-week follow-up via text or emailthrough study completion, an average of 6 weeks"1 = I got what I needed" "2 = I didn't receive anything useful" "3 = I'm still receiving care"
Jefferson Scale of Patient's Perceptions of Physician Empathythrough study completion, an average of 6 weeksThe Jefferson Scale of Patient's Perceptions of Physician Empathy includes five 7-point scale questions and higher scores indicated greater perceived clinician empathy.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDavid Ring, MD

Professor of orthopedic surgery at The university of Texas at Austin

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 10, 2026